metricas
covid
Buscar en
Enfermedades Infecciosas y Microbiología Clínica (English Edition)
Toda la web
Inicio Enfermedades Infecciosas y Microbiología Clínica (English Edition) Modified measles outbreak in vaccinated healthcare workers exposed to primary me...
Información de la revista
Vol. 40. Núm. 6.
Páginas 342-343 (junio - julio 2022)
Vol. 40. Núm. 6.
Páginas 342-343 (junio - julio 2022)
Letter to the Editor
Acceso a texto completo
Modified measles outbreak in vaccinated healthcare workers exposed to primary measles case
Brote de sarampión-modificado en personal sanitario tras exposición a un caso de sarampión clásico
Visitas
422
David Navalpotro-Rodrígueza,
Autor para correspondencia
davidnavalpotro01@gmail.com

Corresponding author.
, Ángel Garay-Moyab,c, Andrea Chong-Valbuenab,d, Mercedes Melero-Garciab
a Servicio de Microbiología, Consorcio Hospital General Universitario de Valencia, Valencia, Spain
b Servicio de Medicina Preventiva, Consorcio Hospital General Universitario de Valencia, Valencia, Spain
c Servicio de Medicina Preventiva, Hospital de Sagunto, Sagunto, Valencia, Spain
d Sección de Epidemiología, Centro de Salud Pública de Valencia, Valencia, Spain
Este artículo ha recibido
Información del artículo
Texto completo
Bibliografía
Descargar PDF
Estadísticas
Tablas (1)
Table 1. Clinical data and relevant vaccination history of patients affected by the outbreak and serological results before and after the onset of measles virus infection.
Texto completo
Dear Editor,

We read with great interest the article by Sanz et al.1 in which they demonstrated the usefulness of IgM detection (DiaSorin, Italy) in confirming cases of measles, using a high-sensitivity, high-specificity method that carries potential advantages in implementation in routine emergency medical care and in microbiology departments. According to the authors, the study had some limitations, such as its limited sample size and the manner of selection of the control group. However, in our opinion there is a matter of particular interest: determining patients' pre-exposure immune situation—that is to say, their measles virus vaccination status.

In Spain, systematic measles vaccination was introduced in 1975, with one dose at the age of nine months. Subsequently, between 1988 and 1995, a second dose at 11 years of age was included and total coverage was achieved in 1995. In 2000, the vaccination schedule was modified to include a first dose of a measles-mumps-rubella vaccine at the age of 12 months and a second dose at the age of 3–4 years. This regimen remains in place today.

This prior immunisation influences the immune response to the infection, which is characterised as a secondary response, with lower IgM production and, therefore, a lower likelihood of detection, and with a rapid and significant increase in IgG2.

In this regard, we would like to offer our experience in a measles outbreak in an occupational setting in March 2018. The outbreak consisted of 10 cases, nine of which were healthcare personnel at a tertiary hospital.

The index case corresponded to a 34-year-old man who visited primary care due to a fever of 39 °C and a rash that spread downwards from his face, sparing the palms of his hands and the soles of his feet, with associated odynophagia and cough. Examination revealed palpable lymphadenopathy behind the ears. The patient was diagnosed with acute tonsillitis and prescribed antibiotic therapy with amoxicillin and clavulanic acid. Five days later, as a result of worsening due to respiratory failure, he required hospital admission.

As measles was suspected, respiratory and contact isolation were indicated. The diagnosis was confirmed by means of serology, with IgM(+) and IgG(−), and by the presence of RNA in a nasopharyngeal sample (genotype B3). In addition, alveolar infiltrate was seen in the right upper lobe, and treatment with levofloxacin was started due to probable bacterial superinfection. He was discharged after eight days, having followed a suitable clinical course.

Nine secondary cases occurred amongst the healthcare personnel who treated the patient prior to implementation of isolation measures. Of them, 66.6% were women, and their mean age was 27.8 years (range 24–36). In all cases, a skin rash developed; in eight of the nine cases, it lasted one day. Cough was present in five cases, coryza in seven cases and conjunctivitis in one case (Table 1).

Table 1.

Clinical data and relevant vaccination history of patients affected by the outbreak and serological results before and after the onset of measles virus infection.

      Clinical symptomsVaccinationSerological historyAntibodies following symptoms
Case  Age  Sex  Duration of exanthema  Cough  Coryza  Conjunctivitis  Dose  Latest  Date  IgGb (IU/mL)  IgMa  IgG (IU/mL) Avidityb  Rash interval 
1 (I)  34  Yes  Yes  Yes        27.0  ND 
29  No  No  No  2017  Mar. '17  84  0.4  >5000 
                        High   
26  Yes  No  No  1999  May '16  166  0.3  >5000 
                        High   
25  No  Yes  No  1999  Mar. '18  75  2.2  >5000 
                        High   
31  Yes  Yes  No  1999  Mar. '18  175  0.2  >5000 
                        High   
25  No  Yes  No  1999  Aug. '17  80  1.9  >5000 
                        High   
24  Yes  Yes  No  1994      2.8  >5000 
                        High   
26  No  Yes  No  2001  Mar. '18  142  0.9  >5000 
                        High   
29  Yes  Yes  No  N/A    Apr. '17  162  >5000 
                        High   
10  36  Yes  Yes  Yes  N/A    Jul. '15  ND  >5000  15 
                        High   

I: index case of the outbreak; N/A: no existing vaccination record; ND: not detectable.

a

IgM (DiaSorin, Italy): (index value) positivity greater than 1.1.

b

IgG measurement (IU/mL) and avidity (Euroimmun, Germany), protective over 200 IU/mL.

Cases were confirmed by means of serology, by seroconversion, an at least fourfold increase in high-avidity IgG titre (>5000) (Euroimmun, Germany), a few days after the onset of the rash, which indicated a booster due to prior immunity. IgM was positive in just five cases (55%) and close to the cut-off point in all cases, in contrast to the index case, who had no history of vaccination. In addition, in three of the cases, the viral RNA detected (from a nasopharyngeal sample) belonged to genotype B3—the same genotype as in the index case. There is no record of any tertiary cases in this outbreak.

Investigation of vaccination status revealed that six patients had received at least one dose of the triple viral vaccine and eight patients had a serological determination of measles (IgG) less than 200 mIU/mL (Euroimmun, Germany) prior to contact with the index case.

In vaccinated people, it is more difficult to detect cases of measles according to microbiological criteria, both because the short period of viral replication makes it difficult to detect viral RNA and because IgM has a weaker presence3,4. This highlights the need to detect high-avidity IgG seroconversion within a few days of the onset of the rash through an at least fourfold increase in its titre, which demonstrates the “booster effect”5,6.

Surveillance of suspected cases of measles-like disease or atypical measles, with common signs and symptoms of limited duration tending to affect young vaccinated individuals, is a major challenge. Such cases may be underdiagnosed, as they are often detected in contact tracing following confirmation of a classic case of measles. In addition, the appearance of these signs and symptoms in countries with high vaccination coverage, such as Spain, points to suboptimal protection due to insufficient vaccine doses or loss of immunity over time7,8.

These particular characteristics of measles necessitate new seroprevalence studies in countries with high vaccination coverage, especially in the young adult population, to identify potentially vulnerable groups by detecting low or absent levels of antibodies9. Protection of this at-risk population, in particular people who may come into contact with classic measles such as health workers, could bear reconsideration of the measles vaccination programme.

References
[1]
J.C. Sanz, B. Ramos, M. Pérez-Olmeda, A. Fernánde-Grcía.
Evaluación de la detección de IgM específicafrente a sarampión mediante el ensayo de inmunoquimioluminiscencia Liaison® measles IgM.
Enferm Infecc Microbiol Clin., (2021),
[2]
C. Risco-Risco, J. Masa-Calles, N. López-Perea, J.E. Echevarría, G. Rodríguez-Caravaca.
Epidemiología del sarampión en personas vacunadas, España 2003-2014.
Enfermedades Infecc Microbiol Clínica., 35 (2017), pp. 569-573
[3]
K.P. Coleman, P.G. Markey.
Measles transmission in immunized and partially immunized air travellers.
Epidemiol Infect., 138 (2010), pp. 1012-1015
[4]
J.B. Rosen, J.S. Rota, C.J. Hickman, S.B. Sowers, S. Mercader, P.A. Rota, et al.
Outbreak of measles among persons with prior evidence of immunity, New York City, 2011.
Clin Infect Dis., 58 (2014), pp. 1205-1210
[5]
C.J. Hickman, T.B. Hyde, S.B. Sowers, S. Mercader, M. McGrew, N.J. Williams, et al.
Laboratory characterization of measles virus infection in previously vaccinated and unvaccinated individuals.
J Infect Dis., 204 (2011), pp. S549-58
[6]
S. Mercader, P. Garcia, W.J. Bellini.
Measles virus IgG avidity assay for use in classification of measles vaccine failure in measles elimination settings.
Clin Vaccine Immunol., 19 (2012), pp. 1810-1817
[7]
J.S. Rota, C.J. Hickman, S.B. Sowers, P.A. Rota, S. Mercader, W.J. Bellini.
Two case studies of modified measles in vaccinated physicians exposed to primary measles cases: high risk of infection but low risk of transmission.
J Infect Dis., 204 (2011), pp. S559-63
[8]
G.F. Augusto, D. Cruz, A. Silva, N. Pereira, B. Aguiar, A. Leça, et al.
Challenging measles case definition: three measles outbreaks in three Health Regions of Portugal, February to April 2018.
[9]
E. Avramovich, V. Indenbaum, M. Haber, Z. Amitai, E. Tsifanski, S. Farjun, et al.
Measles outbreak in a highly vaccinated population — Israel, July–August 2017.
MMWR Morb Mortal Wkly Rep., 67 (2018), pp. 1186-1188

Please cite this article as: Navalpotro-Rodríguez D, Garay-Moya Á, Chong-Valbuena A, Melero-Garcia M. Brote de sarampión-modificado en personal sanitario tras exposición a un caso de sarampión clásico. Enferm Infecc Microbiol Clin. 2022;40:342–343.

Descargar PDF
Opciones de artículo
es en pt

¿Es usted profesional sanitario apto para prescribir o dispensar medicamentos?

Are you a health professional able to prescribe or dispense drugs?

Você é um profissional de saúde habilitado a prescrever ou dispensar medicamentos